Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors - a comprehensive review

被引:2
|
作者
Chachlioutaki, Konstantina [1 ,2 ]
Gioumouxouzis, Christos [1 ]
Karavasili, Christina [1 ]
Fatouros, Dimitrios G. [1 ,2 ,3 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Pharm, Div Pharmaceut Technol, Thessaloniki, Greece
[2] Ctr Interdisciplinary Res & Innovat CIRI AUTH, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Dept Pharm, Div Pharmaceut Technol, GR-54124 Thessaloniki, Greece
关键词
Age-appropriate formulation; compounding/extemporaneous preparation; drug manipulation; medication error; off-label/unlicensed use; pediatric patient; NEONATAL INTENSIVE-CARE; OFF-LABEL USE; HOSPITALIZED CHILDREN; ADMINISTRATION ERRORS; DOSAGE FORMS; DELIVERY DEVICES; ORAL MEDICINES; EVENTS; ACCEPTABILITY; INTERVENTIONS;
D O I
10.1080/17425247.2023.2273838
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
IntroductionMedication errors during drug manipulations in pediatric care pose significant challenges to patient safety and optimal medication management. Epidemiological studies have revealed a high prevalenceof medication errors throughout the medication process. Due to the lack of age-appropriate dosage forms, medication manipulation is common in pediatric drug administration. The consequences of these manipulations on drug efficacy and safety could be devastating, highlighting the need for evidence-based guidelines and standardized compounding practices.Areas coveredThis review focuses on examining medication errors in pediatric care and delving into the manipulation of medicinal products.Expert opinionThe observed prevalence of medication errors and manipulations underscores the importance of addressing these issues to enhance patient safety and improve medication outcomes in pediatric care. Overall, the development of age-appropriate formulations and the dissemination of comprehensive clinical guidelines are essential steps toward improving medication safety and minimizing manipulations in pediatric healthcare settings.
引用
收藏
页码:1489 / 1509
页数:21
相关论文
共 17 条
  • [11] Challenges in Transition of Care for Pediatric Patients after Weight-Reduction Surgery: a Systematic Review and Recommendations for Comprehensive Care
    Sarah B. Cairo
    Indrajit Majumdar
    Aurora Pryor
    Alan Posner
    Carroll M. Harmon
    David H. Rothstein
    Obesity Surgery, 2018, 28 : 1149 - 1174
  • [12] Challenges in Transition of Care for Pediatric Patients after Weight-Reduction Surgery: a Systematic Review and Recommendations for Comprehensive Care
    Cairo, Sarah B.
    Majumdar, Indrajit
    Pryor, Aurora
    Posner, Alan
    Harmon, Carroll M.
    Rothstein, David H.
    OBESITY SURGERY, 2018, 28 (04) : 1149 - 1174
  • [13] Comments on "Challenges in Transition of Care for Pediatric Patients after Weight-Reduction Surgery: a Systematic Review and Recommendations for Comprehensive Care"
    Kassir, Rani
    Michel, Jean-Luc
    Kassir, Radwan
    Sauvat, Frederique
    OBESITY SURGERY, 2018, 28 (08) : 2533 - 2534
  • [14] Comments on “Challenges in Transition of Care for Pediatric Patients after Weight-Reduction Surgery: a Systematic Review and Recommendations for Comprehensive Care”
    Rani Kassir
    Jean-Luc Michel
    Radwan Kassir
    Frédérique Sauvat
    Obesity Surgery, 2018, 28 : 2533 - 2534
  • [15] Response to Letter to the Editor; Comments on “Challenges in Transition of Care for Pediatric Patients after Weight-Reduction Surgery: a Systematic Review and Recommendations for Comprehensive Care”
    Sarah B Cairo
    Indrajit Majumdar
    Aurora Pryor
    Alan Posner
    Carroll M Harmon
    David H Rothstein
    Obesity Surgery, 2018, 28 : 2914 - 2915
  • [16] Response to Letter to the Editor; Comments on "Challenges in Transition of Care for Pediatric Patients after Weight-Reduction Surgery: a Systematic Review and Recommendations for Comprehensive Care"
    Cairo, Sarah B.
    Majumdar, Indrajit
    Pryor, Aurora
    Posner, Alan
    Harmon, Carroll M.
    Rothstein, David H.
    OBESITY SURGERY, 2018, 28 (09) : 2914 - 2915
  • [17] ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASE
    Lepisto, E. M.
    Vandergrift, J. L.
    Kalemkerian, G. P.
    Pisters, K. M.
    Zornosa, C.
    Rabin, M. S.
    Reid, M. E.
    Koczywas, M.
    Otterson, G. A.
    Ettinger, D. S.
    VALUE IN HEALTH, 2011, 14 (03) : A176 - A177